2Stephenson JM, Kenny S, Stevens LK , et al. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med ,1995 ,12(2) :149.
3Ravid M, Neuman L, Lishner M. Plasma lipid and the progression of nephropathy in diabetes mellitus type 11 : effect of ACE inhibitors. Kidney Int, 1995,47:907.
4Islam N, Kazmi F, Chuney GD,et al. Ethnic differences in correlates of microalbuminuria in NIDDM: the role of the acute-phase response. Diab Care, 1998,21 ( 3 ) : 385.
5Stratton, IM , Kohner, EM , Aldington, SJ , et al. UKPDS 50 : risk factors for incidence and progression of retinopathy in type Ⅱ diabetes over 6 years from diagnosis. Diabetologia,2001,44 (2) :156.
6Keen H,Lee ET,Russell D,et al. The appearance of retinopathy and progression to proliferative retinopathy:the WHO Multinational Study of vascular disease in diabetes. Diabetologia,2001 ,44 (Suppl 2) :S22.
7Laakso M. Benefits of strict glucose and blood pressure control in type 2 diabetes-Lessons from the UK prospective diabetes study. Circulation , 1999 ,99 (4):461.
10Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephrepathy: results from the RENAAL study.Arch In tem Med,2003,163 : 1555-1565.
